fbpx
2.4 C
London
Tuesday, December 7, 2021

NASDAQ: ATRC Earns An Average “Buy” Rating From Stock Market Analysts

AtriCure, Inc just received an average of “buy” rating from ten stock market analysts. Out of the ten, one issued a rating of “sell”, one issued a rating of “hold” and eight issued a rating of “buy” to NASDAQ: ATRC. The company’s one year objective price is $52.71. 

How Did The Stock Market Analysts React To NASDAQ: ATRC Report?

Piper Sandler increased its target price on AtriCure shares to $50 from $47. They also issued a rating of “overweight on 29th July during Wednesday’s report. BidaskClus also updated its NASDAQ: ATRCshares to a rating of “Buy” from a rating of “Hold” on 1st September during a Tuesday report. ValuEngine also increased its AtriCure shares to a rating of “buy” from a rating of “hold” on 3rd August during a Monday report. 

- Advertisement -

JPMorgan Chase & Co increased their price target to $57.00 from $48.00 as well. They also issued a rating of “overweight” on 29th July during a Wednesday report. Last but not the least, Zacks Investment Research decreased AtriCure (NASDAQ: ATRC) shares to a rating of “hold” to a rating of “buy” on 29th September during a Tuesday report.

On Monday, AtriCure shares started at $0.10. NASDAQ: ATRC stock has a $1.86 billion market capitalization. Its price to earnings ratio and beta are -31.93 and 0.72. The firm also has $40.82 as its fifty days moving average and $42.10 as its two-hundred days moving average. 

AtriCure Inc’s quick ratio, current ratio, and debt to equity ratio are 6.81, 7.67, and 0.16 respectively. 

Which Investors Increased Or Decreased Their AtriCure Stocks Recently?

- Advertisement -

FMR LLC boosted its NASDAQ: ATRC position by 34.6 percent. They currently own an estimate of $214,268,000, which comes from 4,766,815 company shares.. Vanguard Group Inc also increased its ArtiCure stake by 10.9 percent. They currently own an estimate of $101,953,000, which comes from 2,268,168 company shares. Invesco Ltd also increased its NASDAQ: ATRC stakes by 348.9 percent. They currently own an estimate of $51,587,000, which comes from 1,535,792 company shares. 

Fred Alger Management LLC recently acquired $42,438,000 worth of AtriCure Holdings for the first quarter. Last but not the least, Orbimed Advisors LLC increased its NASDAQ: ATRC stakes by 32.3 percent. They currently own an estimate of $55,207,900, which comes from 1,228,189 company shares. 

It should be noted that 93.50 percent of AtriCure Inc (NASDAQ: ATRC) Stocks are owned by stock market investors and hedge funds. 

On 28th July, AtriCure (NASDAQ: ATRC) revealed that the company’s quarterly earning is $0.38 EPS.

- Advertisement -

Follow Us

16,985FansLike
4,865FollowersFollow
1,643FollowersFollow

Latest news